ELLI, ELENA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 1.158
EU - Europa 667
AS - Asia 150
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.979
Nazione #
US - Stati Uniti d'America 1.145
IT - Italia 199
DE - Germania 174
IE - Irlanda 125
SE - Svezia 98
CN - Cina 70
HK - Hong Kong 44
UA - Ucraina 23
GB - Regno Unito 19
CA - Canada 13
FR - Francia 10
FI - Finlandia 9
IN - India 9
VN - Vietnam 8
SG - Singapore 7
TR - Turchia 5
NO - Norvegia 3
RU - Federazione Russa 3
AU - Australia 2
BG - Bulgaria 2
IR - Iran 2
JO - Giordania 2
JP - Giappone 2
AR - Argentina 1
BE - Belgio 1
CZ - Repubblica Ceca 1
EU - Europa 1
LK - Sri Lanka 1
Totale 1.979
Città #
Ann Arbor 301
Frankfurt am Main 133
Dublin 123
Chandler 122
Woodbridge 90
Fairfield 89
Houston 71
Ashburn 58
Wilmington 55
New York 53
Milan 52
Hong Kong 42
Seattle 32
Princeton 30
Shanghai 27
Cambridge 26
Dearborn 25
Jacksonville 25
Altamura 22
Lawrence 15
Rome 11
Los Angeles 9
Dong Ket 8
Carate Brianza 7
Turin 7
Andover 6
Beijing 6
Fremont 6
London 6
Falls Church 5
Genoa 5
Guangzhou 5
Meda 5
Munich 5
Nanjing 5
Ottawa 5
Pune 5
Boardman 4
Bologna 4
Changsha 4
Helsinki 4
Lachine 4
Nanchang 4
Redmond 4
San Diego 4
Cesena 3
Göttingen 3
Jinan 3
Taiyuan 3
Toronto 3
Agrate Brianza 2
Amman 2
Assago 2
Cesano Maderno 2
Chengdu 2
Cinisello Balsamo 2
Como 2
Corbetta 2
Esslingen am Neckar 2
Hebei 2
Lissone 2
Marseille 2
Milton Keynes 2
Oslo 2
Randazzo 2
Sesto San Giovanni 2
Shenyang 2
Sumirago 2
Treviglio 2
Veniano 2
Vimodrone 2
Véretz 2
Washington 2
Arzano 1
Blackheath 1
Bonndorf 1
Borgarello 1
Brno 1
Brussels 1
Carpi 1
Casoria 1
Colombo 1
Columbia 1
Cremona 1
Desio 1
Easton 1
Falkenstein 1
Fresno 1
Fuzhou 1
Fürstenwalde 1
Garbagnate Milanese 1
Haikou 1
Hangzhou 1
Hounslow 1
Kardzhali 1
Kocaeli 1
Lappeenranta 1
Legnano 1
Magenta 1
Melbourne 1
Totale 1.617
Nome #
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia 186
Good outcome for very high risk adult B-cell acute lymphoblastic leukaemia carrying genetic abnormalities t(4;11)(q21;q23) or t(9;22)(q34;q11), if promptly submitted to allogeneic transplantation, after obtaining a good molecular remission 177
Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients 173
Large-Scale Analysis of SARS-CoV-2 Synonymous Mutations Reveals the Adaptation to the Human Codon Usage During the Virus Evolution 163
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 162
A CASE OF ATYPICAL PROLONGED HEMATOLOGIC TOXICITY WITH AZACITIDINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML), REVIEW OF LITERATURE AND A PROPOSAL OF MANAGEMENT 152
Circulating endothelial cells and endothelial activation in essential thrombocythemia: Results from CD146(+) immunomagnetic enrichment-flow cytometry and soluble E-selectin detection 148
Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors 139
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN 118
Neurological symptoms in essential thrombocythemia: Impact of JAK2V617F mutation and response to therapy 98
Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) study 74
Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis 72
Iron chelation therapy with deferasirox in the management of iron overload in primary myelofibrosis 65
Being a Myeloproliferative Patient in COVID-19 Era: The Mytico Study 59
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 53
JAK2-mutated Langerhans cell histiocytosis associated with primary myelofibrosis treated with ruxolitinib 53
Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era: A Focused Review 40
Clinical and Molecular features of the patients with Idiopathic Erythrocytosis 37
Paired Exome Sequencing Reveals Recurrent Germline Variants in Patients with Idiopathic Erythrocytosis 33
Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia 31
Idiopathic erythrocytosis: a germline disease? 20
Totale 2.053
Categoria #
all - tutte 7.121
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.121


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201943 0 0 0 0 0 0 0 0 0 0 22 21
2019/2020188 18 6 10 17 18 28 34 15 15 12 12 3
2020/2021410 27 19 67 52 31 40 26 34 30 23 40 21
2021/2022217 17 12 18 21 16 19 1 11 16 19 27 40
2022/2023527 45 148 65 50 25 78 11 27 38 5 10 25
2023/2024488 16 25 24 35 58 132 96 22 50 28 2 0
Totale 2.053